Annual report pursuant to Section 13 and 15(d)

Disclosure of Prior Period Financial Statement Error (Details)

v3.20.2
Disclosure of Prior Period Financial Statement Error (Details) - USD ($)
$ / shares in Units, shares in Thousands, $ in Thousands
3 Months Ended 9 Months Ended 12 Months Ended
Mar. 31, 2020
Mar. 31, 2020
Jun. 30, 2020
Jun. 30, 2019
Jun. 30, 2018
Revised Consolidated Balance Sheets          
Subscription receivable $ 0 $ 0 $ 5,549 $ 0  
Total current assets 10,304 10,304 61,748 4,808  
Total assets 42,220 42,220 94,189 30,586  
APIC 150,774 150,774      
Total equity 3,957 3,957 56,607 2,457 $ 16,164
Total liabilities and equity $ 42,220 $ 42,220 $ 94,189 $ 30,586  
Revised Consolidated Statement of Operations          
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted $ (0.06) $ (0.74) $ (0.61) $ (0.94)  
Weighted-average common shares outstanding - basic and diluted 79,719 47,018 62,795 18,926  
Adjustments Due to Error Related to the Omission of a Share Issuance [Member]          
Revised Consolidated Balance Sheets          
Subscription receivable $ 2,190 $ 2,190      
Total current assets 2,190 2,190      
Total assets 2,190 2,190      
APIC 2,190 2,190      
Total equity 2,190 2,190      
Total liabilities and equity $ 2,190 $ 2,190      
Revised Consolidated Statement of Operations          
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted $ 0.00 $ 0.00      
Weighted-average common shares outstanding - basic and diluted 290 96      
Revised Amounts for an Error Related to the Omission of a Share Issuance [Member]          
Revised Consolidated Balance Sheets          
Subscription receivable $ 2,190 $ 2,190      
Total current assets 12,494 12,494      
Total assets 44,410 44,410      
APIC 152,964 152,964      
Total equity 6,147 6,147      
Total liabilities and equity $ 44,410 $ 44,410      
Revised Consolidated Statement of Operations          
Loss per common share attributable to iBio, Inc. stockholders - basic and diluted $ (0.06) $ (0.74)      
Weighted-average common shares outstanding - basic and diluted 80,009 47,114